Profil

Jansen Nicolas

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Coucke, Philippe  (35)
Janvary, Zsolt Levente  (12)
Nickers, Philippe  (8)
Deneufbourg, Jean-Marie  (7)
Mievis, Carole  (7)
Main Referenced Keywords
radiotherapy (7); Humans (6); Oncology (5); prostate (4); Radiology, Nuclear Medicine and imaging (4);
Main Referenced Disciplines
Oncology (45)
Radiology, nuclear medicine & imaging (12)
Human health sciences: Multidisciplinary, general & others (2)
Physics (2)
Treatment & clinical psychology (2)

Publications (total 57)

The most downloaded
9549 downloads
Jansen, N., Nickers, P., & Devoghel, J.-C. (2000). La douleur pelvienne chez le patient oncologique. Oncologie, 2 (4), 187-200. https://hdl.handle.net/2268/3706

The most cited

106 citations (Scopus®)

LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8 https://hdl.handle.net/2268/193388

LOUIS, T., Lucia, F., Cousin, F., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Visvikis, D., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Lovinfosse, P., & Hustinx, R. (19 April 2024). Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence. Scientific Reports, 14 (1), 9028. doi:10.1038/s41598-024-58551-4
Peer Reviewed verified by ORBi

Lucia, F., MIEVIS, C., Jansen, N., Duysinx, B., Cousin, F., LOUIS, T., BAIWIR, M., ERNST, C., WONNER, M., Hustinx, R., Lovinfosse, P.* , & Coucke, P.*. (2024). Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience. Clinical and Translational Radiation Oncology, 100720. doi:10.1016/j.ctro.2023.100720
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Colin, G., Ben Mustapha, S., Jansen, N., Coucke, P., Seidel, L., Berkovic, P., & Janvary, L. (March 2023). Interval From Simulation Imaging to Treatment Delivery in SABR of Lung Lesions: How Long is Too Long for the Lung? Advances in Radiation Oncology, 8 (2), 101132. doi:10.1016/j.adro.2022.101132
Peer Reviewed verified by ORBi

Vaandering, A., Jansen, N., Weltens, C., Moretti, L., Stellamans, K., Vanhoutte, F., Scalliet, P., Remouchamps, V., Lievens, Y., & Belgian College for Physicians in Radiation Oncology. (January 2023). Radiotherapy-specific quality indicators at national level: How to make it happen. Radiotherapy and Oncology, 178, 109433. doi:10.1016/j.radonc.2022.11.022
Peer Reviewed verified by ORBi

Lucia, F., LOUIS, T., Cousin, F., Bourbonne, V., Visvikis, D., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of [ 18 F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06510-y
Peer Reviewed verified by ORBi

BEN MUSTAPHA, S., Simoni, P., DUBOIS, N., JANSEN, N., Lakosi, F., Silva Mota, A., Ramella, S., & COUCKE, P. (March 2022). The COVID-19 Status of Patients Is an Essential Determinant for Decision-Making by Radiation Oncologists: A European Survey. Cureus, 14 (3), 22842. doi:10.7759/cureus.22842
Peer reviewed

Ghassan, H., Jansen, N., & Coucke, P. (August 2021). PO-1052 Cyberknife stereotactic radiotherapy for vestibular schwannomas :a single institution experience. Radiotherapy and Oncology, 161, 876. doi:10.1016/s0167-8140(21)07503-4
Peer Reviewed verified by ORBi

Berkovic, P., GULYBAN, A., Defraene, G., Swenen, L., Dechambre, D., NGUYEN, P. V., Jansen, N., MIEVIS, C., LOVINFOSSE, P., Janvary, L., Lambrecht, M., & De Meerleer, G. (2020). Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases. BMC Cancer, 20 (1), 402. doi:10.1186/s12885-020-06906-1
Peer Reviewed verified by ORBi

Etienne, A.-M., Gamin, N., JANSEN, N., Coucke, P., & Simon, J. (20 May 2019). Vidéo virtuelle, radiothérapie stéréotaxique et diminution de l’anxiété : quel enjeu pour le patient ? [Poster presentation]. La qualité de vie au coeur des soins de première ligne : Evaluations, applications et persepctives, Liège, Belgium.

Gamin, N., JANSEN, N., COUCKE, P., Etienne, A.-M., & Simon, J. (14 May 2019). Virtual reality: A tool in the treatment of anxiety in stereotaxic radiotherapy? [Poster presentation]. BAPS, Liège, Belgium.

BEN MUSTAPHA, S., Meijnders, P., COUCKE, P., JANSEN, N., & lakosi, F. (2019). The status of radiation oncology (RO) teaching to medical students in Europe. Clinical and Translational Radiation Oncology. doi:10.1016/j.ctro.2019.04.010
Peer Reviewed verified by ORBi

Wink, K., Roelofs, E., Ii, C., Dechambre, D., Santiago, A., Van Der Stoep, J., Dries, W., Smits, J., Avery, S., Ammazzalorso, F., Jansen, N., Jelen, U., Solberg, T., De Ruysscher, D., & Troost, E. (12 March 2018). Photons, protons or carbon ions for stage I non-small cell lung cancer -Results of the multicentric ROCOCO in silico study. Radiotherapy and Oncology, 128 (1), 139-146. doi:10.1016/j.radonc.2018.02.024
Peer Reviewed verified by ORBi

Dechambre, D., Janvary, L. Z., Jansen, N., Berkovic, P., MIEVIS, C., Baart, V., CUCCHIARO, S., Coucke, P., & Gulyban, A. (January 2018). Prediction of GTV median dose differences eases Monte Carlo re-prescription in lung SBRT. Physica Medica, 45, 88-92. doi:10.1016/j.ejmp.2017.12.002
Peer Reviewed verified by ORBi

BEGUIN, C., Jansen, N., & LOLY, C. (2018). Metastase atypique d'un cancer colo-rectal : le pont est mine ! Revue Médicale de Liège, 73 (7-8), 419-424.
Peer reviewed

Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006
Peer Reviewed verified by ORBi

Janvary, Z. L., JANSEN, N., BAART, V., DEVILLERS, M., DECHAMBRE, D., LENAERTS, E., SEIDEL, L., BARTHELEMY, N., BERKOVIC, P., GULYBAN, A., lakosi, F., zsolt, H., & COUCKE, P. (2017). Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiology and Oncology, 51 (2), 178-186. doi:10.1515/raon-2017-0015
Peer Reviewed verified by ORBi

Dechambre, D., Baart, V., CUCCHIARO, S., ERNST, C., Jansen, N., Berkovic, P., MIEVIS, C., Coucke, P., & Gulyban, A. (January 2017). Commissioning Monte Carlo algorithm for robotic radiosurgery using cylindrical 3D-array with variable density inserts. Physica Medica, 33, 152-158. doi:10.1016/j.ejmp.2017.01.005
Peer Reviewed verified by ORBi

LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8
Peer Reviewed verified by ORBi

LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542
Peer Reviewed verified by ORBi

JANVARY, Z. L., JANSEN, N., & COUCKE, P. (2014). LE CYBERKNIFE AIME LES DEFIS ! Aperçu d'indications pour la radiothérapie extracrânienne robotisée. Revue Médicale de Liège, 69 (Supp 1), 87-93.
Peer reviewed

COUCKE, P., JANVARY, Z. L., & JANSEN, N. (2014). L’INTÉRÊT DE LA RADIOTHÉRAPIE «ABLATIVE» EN PRENANT COMME MODÈLE LA MÉTASTASE D’UN CANCER RÉNAL À CELLULES CLAIRES. Revue Médicale de Liège, 69 (Supp 1), 94-100.
Peer reviewed

LOVINFOSSE, P., JANVARY, Z. L., JANSEN, N., DISTER, F., FRUSCH, N., DUYSINX, B., COUCKE, P., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with lung tumors treated by Cyberknife. Journal of Nuclear Medicine, 54 (SUPPL), 567.
Peer Reviewed verified by ORBi

JANSEN, N. (26 April 2012). Reimbursement of radiotherapy in Belgium [Paper presentation]. Benelux User Meeting, Scheveningen, Netherlands.

JANSEN, N. (2012). Le futur centre intégré d'oncologie de Liège (CIO) : analyse des besoins de l'équipe de radiothérapie-oncologie. L'application des principes de 'healing environment'.

JANSEN, N., SOBCZAK, S., RUYANGE, B. W., & CHOUFFART, L. (2012). La radiothérapie des cancers urologiques : cours d'introduction pour l'ensemble des intervénants médicaux et non-médicaux. (ULiège - Université de Liège).

BARTHELEMY, N., JANSEN, N., GENNIGENS, C., DELGAUDINE, M., & COUCKE, P. (2012). y a-t-il une place pour la radiothérapie en fin de vie ? Revue Médicale de Liège, 67 (3), 128/132.
Peer reviewed

LALLEMAND, F., JANVARY, Z. L., JANSEN, N., & COUCKE, P. (November 2011). Cyberknife et pathologies bénignes. Revue Médicale de Liège, 66 (11), 568-574.
Peer reviewed

JANSEN, N., & COUCKE, P. (15 October 2011). Cyberknife for lung tumors : the first Belgian experience at CHU Liege and initiated research projects [Paper presentation]. AERO meeting 2011, Istanbul, Turkey.

JANSEN, N. (29 April 2011). Stereotactic Cyberknife based radiotherapy: introduction and possible dosimetric comparisons with other treatment techniques [Paper presentation]. Radiotherapy meeting, Brussels, Belgium.

Jansen, F. H., Adoubi, I., Kouassi, C. J. C., De Cnodder, T., JANSEN, N., Tschulakow, A., & Efferth, T. (2011). First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Research, 31 (12), 4417-4422.
Peer Reviewed verified by ORBi

JANVARY, Z. L., JANSEN, N., MARTINIVE, P., & COUCKE, P. (2011). New indications for radiotherapy: primary liver cancer and secondary liver oligometastases. Belgian Journal of Medical Oncology, 5 (1), 8-13.
Peer Reviewed verified by ORBi

COUCKE, P., JANSEN, N., JANVARY, Z. L., LOUIS, C., VANDERICK, J., RORIVE, A., COLLIGNON, J., LIFRANGE, E., MAWEJA, S., & JERUSALEM, G. (2011). Accelerated partial breast irradiation: state of the art. Belgian Journal of Medical Oncology, 5 (1), 3-7.
Peer Reviewed verified by ORBi

DELGAUDINE, M., LENAERTS, E., JANSEN, N., & COUCKE, P. (2011). Implementation of an Experience feed back committee (EFBC) and impact on prevention and risk management in radiotherapy [Poster presentation]. ASQUA.

COUCKE, P., JANVARY, Z. L., BAART, V., DEVILLERS, M., JANSEN, N., & LENAERTS, E. (2011). Ai-je bien entendu ? Je peux me faire traiter autrement que par chirurgie pour mon schwannome de l’acoustique. Revue Médicale de Liège, 66 (10), 521-528.
Peer reviewed

COUCKE, P., LAKOSI, F., RORIVE, A., JANVARY, Z. L., COLLIGNON, J., JANSEN, N., ANDRE, C., & JERUSALEM, G. (2011). Radiothérapie et cancer du sein : "standards" de traitement, prédiction de rechute locale et questions ouvertes. Revue Médicale de Liège, 66 (5-6), 320-325.
Peer reviewed

JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM [Poster presentation]. Congrès.

JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM. Radiotherapy and Oncology, 96 (supp 1).
Peer Reviewed verified by ORBi

DELGAUDINE, M., JANSEN, N., & COUCKE, P. (September 2010). Experience feed back committee (EFBC) in radiotherapy [Poster presentation]. ESTRO.

COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22.
Peer reviewed

Coucke, P., Jansen, N., Collignon, J., Janvary, Z. L., Rorive, A., Vanderick, J., & Jerusalem, G. (January 2010). Pourquoi les traitements de radiothérapie adjuvante pour cancer du sein ne comptent-ils plus autant de séances ? Revue Médicale de Liège, 65 (1), 10-14.
Peer reviewed

Hermesse, J., Biver, S., JANSEN, N., LENAERTS, E., De Patoul, N., Vynckier, S., COUCKE, P., Scalliet, P., & Nickers, P. (2009). A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlentherapie und Onkologie, 185 (11), 736-742. doi:10.1007/s00066-009-2009-5
Peer Reviewed verified by ORBi

Mievis, C., Jansen, N., Schleich, F., Gennigens, C., Rorive, A., Jerusalem, G., Fillet, G., & Sautois, B. (2009). Le cas clinique du mois. Reaction de rappel d'irradiation induite par l'administration de cyclophosphamide. Revue Médicale de Liège, 64 (4), 179-81.
Peer reviewed

Coucke, P., Barthelemy, N., Jansen, N., Trivière, N., & Jerusalem, G. (February 2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter la radiothérapie pour certaines patientes opérées ? Revue Médicale de Liège, 63 (2), 75-81.
Peer reviewed

Coucke, P., Barthelemy, N., Jansen, N. (Other coll.), Triviere, N. (Other coll.), & Jerusalem, G. (Other coll.). (2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter les radiothérapie pour certaines patientes opérées? Revue Médicale de Liège, 63 (2), 75-81.
Peer reviewed

Hermesse, J., Thissen, B., Warlimont, B., Jansen, N., Coucke, P., & Niockers, P. (2008). Analysis of Dose Volume Histogram Differences between High Dose Rate Brachytherapy and Intensity Modulated Radiotherapy for Prostate Treatment. International Journal of Radiation, Oncology, Biology, Physics, 72 (1 (supplément)), 566. doi:10.1016/j.ijrobp.2008.06.140
Peer Reviewed verified by ORBi

Jansen, N., Deneufbourg, J.-M., & Nickers, P. (15 March 2007). Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation. International Journal of Radiation, Oncology, Biology, Physics, 67 (4), 1052-1058. doi:10.1016/j.ijrobp.2006.10.031
Peer Reviewed verified by ORBi

Jansen, N., & Nickers, P. (October 2006). A new technique of stereotactic permanent breast seed implantation. Radiotherapy and Oncology, 81 (Suppl. 1), 249-S250.
Peer Reviewed verified by ORBi

Meyns, M., Jansen, N., & Deneufbourg, J.-M. (September 2006). Place de la radiotherapie dans le traitement du cancer du sein. Indications actuelles et perspectives. Revue Médicale de Liège, 61 (9), 623-31.
Peer reviewed

Nickers, P., Coppens, L., De Leval, J., Jansen, N., & Deneufbourg, J.-M. (June 2006). 192ir Low Dose Rate Brachytherapy for Boosting Locally Advanced Prostate Cancers after External Beam Radiotherapy: A Phase Ii Trial. Radiotherapy and Oncology, 79 (3), 329-34. doi:10.1016/j.radonc.2006.05.013
Peer Reviewed verified by ORBi

Jansen, N., Nickers, P., & Deneufbourg, J.-M. (February 2006). L'irradiation partielle du sein et le role de la curietherapie: une nouvelle approche therapeutique pour les carcinomes mammaires de bon pronostic. Revue Médicale de Liège, 61 (2), 97-103.
Peer reviewed

Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002
Peer Reviewed verified by ORBi

Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (October 2004). 192lr LDR brachytherapy(BT) is at least as efficient as HDR options for boosting unfavourable prostate cancers after EBRT. Proposals for future prospects. Radiotherapy and Oncology, 73 (Suppl. 1), 83.
Peer Reviewed verified by ORBi

Nickers, P., Jansen, N., Thissen, B., & Deneufbourg, J.-M. (May 2004). 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients. Radiotherapy and Oncology, 71 (Suppl. 2), 124-S125.
Peer Reviewed verified by ORBi

Jansen, N. (2004). Radiothérapie - Une explication pas à pas de l'irradiation. Kessel-Lo, Belgium: Garant.

Jansen, N. (2001). Radiotherapie - Stap-voor-stap uitleg over bestraling. Kessel-Lo, Belgium: Garant.

Jansen, N., Nickers, P., & Devoghel, J.-C. (2000). La douleur pelvienne chez le patient oncologique. Oncologie, 2 (4), 187-200.
Peer Reviewed verified by ORBi

Jansen, N. (2000). Radiotherapie - Stap-voor-stap uitleg over bestraling. Kessel-Lo, Belgium: Garant.

Contact ORBi